ArticlePsychopharmacology2026
Histone deacetylase inhibitor sodium butyrate increases risk-taking during acquisition of the rat gambling task.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
rationalePairing casino-inspired audiovisual cues with reward delivery significantly increases risky decision-making in laboratory-based gambling tasks across rats and humans. The neurocognitive mechanisms underlying this effect are unclear. Data from the rat gambling task (rGT) suggests win-paired cues render choice insensitive to reinforcer devaluation, indicating habitual control of decision-making. Histone deacetylase enzymes (HDACs) negatively mediate gene expression. Inhibiting this process can facilitate the formation of long-term memories and accelerate habit formation.
objectiveWe therefore hypothesised that risky decision making in the cued rGT could be enhanced by administration of the non-specific class I HDAC inhibitor sodium butyrate (NaBut).
methodsMale Long Evans rats received NaBut after each cued rGT session during task acquisition.
resultsNaBut-treated rats developed a bias towards the risky options more rapidly during the first five training sessions. Immunohistochemical analysis indicated a relative increase in histone acetylation in the striatum and prelimbic frontal cortex after five days of NaBut treatment. Modeling the data using previously established reinforcement learning algorithms optimised for the rGT suggests that NaBut concurrently increased learning from rewards while also decreasing learning from punishments during this early learning period. However, once training was complete, NaBut-treated animals were just as sensitive as controls to the omission of reward, although behavioural changes were less apparent in risk-preferring rats.
conclusionsThese findings suggest that development of a maladaptive, risky strategy while learning the cued rGT can be facilitated through HDAC inhibition, but fall short of conclusively demonstrating that such treatment results in greater habitual control over behaviour.
Indexed as
Identifiers
41193859What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.